05/2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
September, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Jun »
05/2024
May 23, 2024, 13:22 |
Blog
Wei Zhang: Blast from the past
Wei Zhang, Director of Center for Cancer Genomics and Precision Oncology at Wake Forest Baptist…
May 23, 2024, 13:21 |
Societies
Join our Scientific Symposium Celebrating Steven A. Rosenberg's 50 Years - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: “Register Now: Join us at our Scientific…
May 23, 2024, 13:17 |
Insight
Julie McCrossin: Helpful insights and practical tips for fellow patients receiving radiation therapy for a brain tumour
Julie McCrossin, Broadcaster, MC, Cancer Survivor and Community Educator, shared on LinkedIn: “Helpful insights and…
May 23, 2024, 13:10 |
Societies
Updated ESMO Clinical Practice Guideline on Renal Cell Carcinoma - ESMO
ESMO – European Society for Medical Oncology posted on LinkedIn: “Updated Renal Cell Carcinoma: ESMO…
May 23, 2024, 13:08 |
Blog
Miguel Bronchud: Too many different treatments options for some cancer patients? Or not enough?
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: “Too many different treatments options…
May 23, 2024, 13:06 |
Drugs
Ajay Major: Outcomes for DLBCL in CR at time of CAR-T infusion from CIBMTR
Ajay Major, Assistant Professor at the University of Colorado School of Medicine, recently shared a…
May 23, 2024, 13:04 |
Blog
Tom Powles on the NADINA trial
Tom Powles, Director of Barts Cancer Center, shared a post on X: "The NADINA trial…
May 23, 2024, 13:01 |
Insight
A neural epigenetic signature is prognostic in patients with glioblastoma - Nature Medicine
Nature Medicine recently shared a post on X: "A neural epigenetic signature detectable via plasma…
May 23, 2024, 12:46 |
Blog
ESMO - This novel combination therapy holds great promise for BRCA-mutated metastatic Breast Cancers
ESMO shared a post on LinkedIn: "ESMOBreast24: phase 2 data on combining olaparib, durvalumab, and fulvestrant…
May 23, 2024, 12:42 |
Opinion
Megan Hall: My colleague John Hennessy just shared the travel-time disparities in access to proton beam therapy for cancer treatment
Megan Hall, Chief Marketing and Creative Officer at Entrée Health, recently shared a post on…
72
73
74
75
76
All:
2435
Posts:
731 - 740
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube